{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T06:34:04Z","timestamp":1780814044564,"version":"3.54.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.nmd.2008.05.003","type":"journal-article","created":{"date-parts":[[2008,6,26]],"date-time":"2008-06-26T05:05:53Z","timestamp":1214456753000},"page":"572-578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Caveolinopathy \u2013 New mutations and additional symptoms"],"prefix":"10.1016","volume":"18","author":[{"given":"Ahmed","family":"Aboumousa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Hoogendijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Charlton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Barresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Voit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hilton-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Eagle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Bushby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Straub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2008.05.003_bib1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/ng0498-365","article-title":"Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy","volume":"18","author":"Minetti","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.nmd.2008.05.003_bib2","doi-asserted-by":"crossref","first-page":"6525","DOI":"10.1074\/jbc.272.10.6525","article-title":"Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins","volume":"272","author":"Couet","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nmd.2008.05.003_bib3","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1471-4914(01)02105-0","article-title":"Caveolae and caveolin-3 in muscular dystrophy","volume":"7","author":"Galbiati","year":"2001","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.nmd.2008.05.003_bib4","doi-asserted-by":"crossref","first-page":"15160","DOI":"10.1074\/jbc.271.25.15160","article-title":"Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins","volume":"271","author":"Song","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nmd.2008.05.003_bib5","doi-asserted-by":"crossref","first-page":"38048","DOI":"10.1074\/jbc.M005321200","article-title":"Caveolin-3 directly interacts with the C-terminal tail of beta \u2013dystroglycan. Identification of a central WW-like domain within caveolin family members","volume":"275","author":"Sotgia","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nmd.2008.05.003_bib6","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/hmg\/7.5.871","article-title":"Caveolin-3 in muscular dystrophy","volume":"7","author":"McNally","year":"1998","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2008.05.003_bib7","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/1096-8628(2001)9999:9999<::AID-AJMG1168>3.0.CO;2-O","article-title":"Mutations in the caveolin-3 gene: When are they pathogenic?","volume":"99","author":"de Paula","year":"2001","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.nmd.2008.05.003_bib8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ana.20350","article-title":"Autosomal recessive rippling muscle disease with homozygous CAV3 mutations","volume":"57","author":"Kubisch","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2008.05.003_bib9","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.nmd.2006.04.006","article-title":"Novel splice site mutation in the caveolin-3 gene leading to autosomal recessive limb girdle muscular dystrophy","volume":"16","author":"Muller","year":"2006","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2008.05.003_bib10","doi-asserted-by":"crossref","first-page":"25632","DOI":"10.1074\/jbc.274.36.25632","article-title":"Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). Retention of LGMD-1C caveolin-3 mutants within the golgi complex","volume":"274","author":"Galbiati","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nmd.2008.05.003_bib11","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1016\/j.yexcr.2006.05.010","article-title":"Altered caveolin-3 expression disrupts PI(3) kinase signaling leading to death of cultured muscle cells","volume":"312","author":"Smythe","year":"2006","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.nmd.2008.05.003_bib12","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1212\/WNL.52.7.1453","article-title":"Phenotypic variability in rippling muscle disease","volume":"52","author":"Vorgerd","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2008.05.003_bib13","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0002-9440(10)65354-0","article-title":"Multiplex Western blotting system for the analysis of muscular dystrophy proteins","volume":"154","author":"Anderson","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.nmd.2008.05.003_bib14","series-title":"Muscular dystrophy methods and protocols","article-title":"Immunocytochemical analysis","author":"Johnson","year":"2001"},{"key":"10.1016\/j.nmd.2008.05.003_bib15","unstructured":"Herrmann RRJ, Kutzick C, Anderson L et al., A new mutation in the transmembrane domain of Caveolin-3 in a patient with percussion-induced rapid muscle contractions. In: 9th world muscle society. Goteborg, Sweden: neuromuscular disorders; 2004. p. 606."},{"key":"10.1016\/j.nmd.2008.05.003_bib16","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1212\/WNL.57.12.2273","article-title":"A sporadic case of rippling muscle disease caused by a de novo caveolin-3 mutation","volume":"57","author":"Vorgerd","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2008.05.003_bib17","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1093\/oxfordjournals.hmg.a018926","article-title":"Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy","volume":"9","author":"Herrmann","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2008.05.003_bib18","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/90050","article-title":"Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease","volume":"28","author":"Betz","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.nmd.2008.05.003_bib19","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/mus.20092","article-title":"Phenotypic variability associated with Arg26Gln mutation in caveolin3","volume":"30","author":"Fee","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2008.05.003_bib20","doi-asserted-by":"crossref","first-page":"20698","DOI":"10.1074\/jbc.272.33.20698","article-title":"Association of phosphofructokinase-M with caveolin-3 in differentiated skeletal myotubes. Dynamic regulation by extracellular glucose and intracellular metabolites","volume":"272","author":"Scherer","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nmd.2008.05.003_bib21","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1016\/S0002-9440(10)63616-4","article-title":"Phosphofructokinase muscle-specific isoform requires caveolin-3 expression for plasma membrane recruitment and caveolar targeting: implications for the pathogenesis of caveolin-related muscle diseases","volume":"163","author":"Sotgia","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.nmd.2008.05.003_bib22","doi-asserted-by":"crossref","first-page":"12670","DOI":"10.1073\/pnas.0402053101","article-title":"Insulin resistance in skeletal muscles of caveolin-3-null mice","volume":"101","author":"Oshikawa","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nmd.2008.05.003_bib23","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1096\/fj.05-4661fje","article-title":"Spatial and temporal regulation of GLUT4 translocation by flotillin-1 and caveolin-3 in skeletal muscle cells","volume":"20","author":"Fecchi","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.nmd.2008.05.003_bib24","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1212\/WNL.44.10.1915","article-title":"A rippling muscle disease gene is localized to 1q41: evidence for multiple genes","volume":"44","author":"Stephan","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2008.05.003_bib25","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/mus.20593","article-title":"CAV3 gene mutation analysis in patients with idiopathic hyper-CK-emia","volume":"34","author":"Reijneveld","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2008.05.003_bib26","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s00415-003-0234-x","article-title":"Variable reduction of caveolin-3 in patients with LGMD2B\/MM","volume":"250","author":"Walter","year":"2003","journal-title":"J Neurol"},{"issue":"4","key":"10.1016\/j.nmd.2008.05.003_bib27","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1136\/jmg.2003.013953","article-title":"FKRP (826C>A) frequently causes limb-girdle muscular dystrophy in German patients","volume":"41","author":"Walter","year":"2004","journal-title":"J Med Genet"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896608001302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896608001302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:55:54Z","timestamp":1760774154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896608001302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0960896608001302"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2008.05.003","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Caveolinopathy \u2013 New mutations and additional symptoms","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2008.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}